Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06906744

Quantitative Assessment of Signal Loss in Cardiotocography Using External Recording

Signal loss in cardiotocography (CTG) recordings is numerous and frequent, whether due to artifacts in signal acquisition or confusion over inadvertent maternal heart rate recording, with various negative consequences for neonatal morbidity and unnecessary obstetric interventions. Data on this issue are 10 to 15 years old. CTG remains the primary method for assessing fetal well-being during labor, almost systematically.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Maternal Heart Rate

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

Primary location

Service de Gynécologie-Obstétrique CMCO - CHU de Strasbourg - France

Strasbourg, 67091, France

Location status: Recruiting

Location contact

Armony LAURENT, Midwife

SUB_INVESTIGATOR

Georges-Emmanuel ROTH, Midwife

CONTACT

[email protected]

33.3.69.55.35.46

Georges-Emmanuel ROTH, Midwife

PRINCIPAL_INVESTIGATOR

Sandra BEL, MD

SUB_INVESTIGATOR

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult female (≥ 18 years old)
  • Patient treated at a hospital between February 1, 2024 and February 28, 2024
  • Having undergone cardiotocography in the labor and delivery room
  • Gestational age at delivery >36 weeks

Exclusion criteria

  • Patient who has expressed opposition to the use of medical record data
  • Patient without CTG
  • Gestational age at delivery <36 weeks

Treatment and study plan

Primary outcomes

  1. Percentage of signal loss during fetal heart rate (FHR) recording during labor.

    Time frame: during labor

Study contacts

Contact information is provided by the study sponsor or research team.

Georges-Emmanuel ROTH, Midwife

CONTACT

[email protected]

33.3.69.55.35.46

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: RCFLoS

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Apr 2, 2025
Registry last updated
Apr 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.